Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VRDN
DateTimeSourceHeadlineSymbolCompany
10/06/202212:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
10/06/202212:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
10/06/202212:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
10/06/202212:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
03/06/202213:00GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
01/06/202213:00GlobeNewswire Inc.Viridian Therapeutics to Participate in June Investor ConferencesNASDAQ:VRDNViridian Therapeutics Inc
31/05/202221:41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRDNViridian Therapeutics Inc
20/05/202212:05TipRanksWedbush Sticks to Its Buy Rating for Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
19/05/202221:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRDNViridian Therapeutics Inc
14/05/202205:18TipRanksViridian Therapeutics (VRDN) Receives a Buy from SVB SecuritiesNASDAQ:VRDNViridian Therapeutics Inc
13/05/202212:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRDNViridian Therapeutics Inc
13/05/202211:55TipRanksAnalysts’ Top Healthcare Picks: Pacira Pharmaceuticals (PCRX), Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
13/05/202211:45TipRanksLadenburg Thalmann & Co. Thinks Viridian Therapeutics’ Stock is Going to RecoverNASDAQ:VRDNViridian Therapeutics Inc
13/05/202205:25TipRanksAnalysts Offer Insights on Healthcare Companies: Ibio (IBIO) and Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
12/05/202222:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
12/05/202221:05GlobeNewswire Inc.Viridian Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate UpdatesNASDAQ:VRDNViridian Therapeutics Inc
03/05/202213:00GlobeNewswire Inc.Viridian Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 12, 2022NASDAQ:VRDNViridian Therapeutics Inc
27/04/202222:14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VRDNViridian Therapeutics Inc
06/04/202213:00GlobeNewswire Inc.Viridian Therapeutics to Participate in The 21st Annual Needham Virtual Healthcare Conference on April 14NASDAQ:VRDNViridian Therapeutics Inc
05/04/202223:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
05/04/202214:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
04/04/202221:05GlobeNewswire Inc.Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules CapitalNASDAQ:VRDNViridian Therapeutics Inc
30/03/202203:25TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Align Tech (ALGN), Karyopharm Therapeutics (KPTI)NASDAQ:VRDNViridian Therapeutics Inc
21/03/202220:05GlobeNewswire Inc.Viridian Therapeutics Doses First Subject in First-in-Human Clinical Trial Evaluating VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye DiseaseNASDAQ:VRDNViridian Therapeutics Inc
16/03/202210:55TipRanksAnalysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
16/03/202200:10TipRanksViridian Therapeutics (VRDN) Gets a Buy Rating from OppenheimerNASDAQ:VRDNViridian Therapeutics Inc
14/03/202222:36TipRanksOppenheimer Bets on These 2 Stocks; Sees Over 40% Upside PotentialNASDAQ:VRDNViridian Therapeutics Inc
14/03/202220:05GlobeNewswire Inc.Viridian Therapeutics to Participate in 32nd Annual Oppenheimer Healthcare Conference on March 15NASDAQ:VRDNViridian Therapeutics Inc
13/03/202209:04TipRanksLeerink Partners Believes Viridian Therapeutics (VRDN) Won’t Stop HereNASDAQ:VRDNViridian Therapeutics Inc
12/03/202209:07TipRanksLadenburg Thalmann & Co. Believes Viridian Therapeutics (VRDN) Won’t Stop HereNASDAQ:VRDNViridian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VRDN

Your Recent History

Delayed Upgrade Clock